Rank,Term name,P-value,Z-score,Combined score,Overlapping genes,Adjusted p-value,Old p-value,Old adjusted p-value,gene count
1,Cytoplasmic Ribosomal Proteins WP477,6.286550931388087e-52,39.036144578313255,4602.205779669437,"['RPL30', 'RPL3', 'RPL32', 'RPL34', 'RPLP1', 'RPL10A', 'RPL9', 'RPL7', 'RPS4X', 'RPS15', 'RPL7A', 'RPS14', 'RPS16', 'RPL18A', 'RPS19', 'RPS18', 'RPL36', 'RPL35', 'RPLP2', 'RPL38', 'RPL39', 'RPS10', 'RPS13', 'RPS12', 'RPS9', 'RPS7', 'RPL21', 'RPS8', 'RPL23', 'RPS6', 'RPL22', 'RPS3A', 'RPL37A', 'RPL24', 'RPL27', 'RPL26', 'RPL29', 'RPL10', 'RPL12', 'RPL11', 'RPL36A', 'RPS15A', 'RPL13', 'RPS2', 'RPS27A', 'RPL18', 'RPL17', 'RPL19', 'RPL41', 'RPL35A', 'RPS26', 'RPS25', 'RPS28', 'RPS27', 'RPS29', 'RPL27A', 'FAU', 'RPS21', 'RPS24', 'RPS23']",1.8230997701025453e-49,0,0,60
2,Electron Transport Chain (OXPHOS system in mitochondria) WP111,1.2811091712331934e-25,17.053309392607268,977.4428475789055,"['NDUFB9', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'COX4I1', 'COX17', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'ATP5MC1', 'ATP5IF1', 'UQCRFS1', 'ATP5MF', 'ATP5ME', 'ATP5PF', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFC1', 'COX6C', 'ATP5F1E', 'COX6B1', 'UQCRQ', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'SLC25A5']",1.8576082982881304e-23,0,0,37
3,Nonalcoholic fatty liver disease WP4396,1.9409719649049435e-15,7.779729906909663,263.542921455997,"['NDUFB9', 'NDUFA13', 'COX7B', 'NDUFB8', 'NDUFB7', 'NDUFB10', 'NDUFA12', 'NDUFB11', 'COX4I1', 'NDUFB3', 'NDUFB2', 'NDUFB1', 'COX7A2', 'UQCR11', 'UQCR10', 'COX5B', 'COX7A1', 'COX7C', 'UQCRH', 'UQCRFS1', 'NDUFA6', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFC1', 'COX6C', 'COX6B1', 'UQCRQ', 'NDUFS6', 'DDIT3', 'NDUFS5', 'BAX']",1.8762728994081122e-13,0,0,32
4,Mitochondrial complex I assembly model OXPHOS system WP4324,2.0653210983093013e-13,15.464585834333734,451.69457943426477,"['NDUFB9', 'NDUFA13', 'NDUFB8', 'NDUFB7', 'NDUFA6', 'DMAC1', 'NDUFB10', 'NDUFA5', 'NDUFA12', 'DMAC2', 'NDUFB11', 'NDUFB3', 'NDUFA2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'NDUFS6', 'NDUFS5', 'TMEM126B']",1.4973577962742436e-11,0,0,19
5,Oxidative phosphorylation WP623,4.226874030536076e-12,11.941895766571092,312.75297653682605,"['NDUFB9', 'ATP5PF', 'NDUFB8', 'NDUFB7', 'NDUFA6', 'NDUFB10', 'NDUFA5', 'NDUFA4', 'NDUFA2', 'NDUFB2', 'NDUFB1', 'NDUFC1', 'ATP5F1E', 'ATP5MC1', 'NDUFS6', 'NDUFS5', 'ATP5PO', 'ATP5MF', 'ATP5ME']",2.4515869377109244e-10,0,0,19
6,Mitochondrial CIV Assembly WP4922,3.4309746550290394e-09,13.691743119266055,266.857843918578,"['COX7B', 'COX16', 'PET100', 'NDUFA4', 'COX4I1', 'COX17', 'COX7A2', 'COX5B', 'COX6C', 'COX7C', 'COX6B1', 'SCO2', 'COX14']",1.658304416597369e-07,0,0,13
7,Mitochondrial complex III assembly WP4921,7.03847460714759e-05,13.530797101449275,129.37517644328926,"['UQCC3', 'UQCRQ', 'UQCRFS1', 'UQCR11', 'UQCR10', 'UQCRH']",0.002915939480104002,0,0,6
8,Nanoparticle triggered regulated necrosis WP2513,0.0012648138671160286,40.4,269.5823444532449,"['TRADD', 'FADD', 'FTL']",0.04584950268295603,0,0,3
9,Ciliary landscape WP4352,0.020482525662214427,2.0256037119055152,7.875918247671402,"['NDUFA5', 'CAMK2A', 'COPS7A', 'MYL6B', 'COX6C', 'COPS6', 'EXOSC4', 'DNPEP', 'TTC30B', 'PSMC4', 'XPNPEP3', 'TNKS1BP1', 'SNRPB2']",0.6095500726933369,0,0,13
10,Proteasome Degradation WP183,0.02101896802390817,3.114130434782609,12.027799432381231,"['PSMC5', 'H2AFZ', 'PSMC4', 'PSMC1', 'HLA-B', 'PSMB10']",0.6095500726933369,0,0,6
11,Type 2 papillary renal cell carcinoma WP4241,0.02651581430956776,4.144404332129964,15.04424557150931,"['SETD2', 'EPAS1', 'COL21A1', 'ELOB']",0.669073711863103,0,0,4
12,Nanomaterial induced apoptosis WP2507,0.02768580876674909,5.766795366795367,20.68454528152996,"['ENDOG', 'BAX', 'FADD']",0.669073711863103,0,0,3
13,Cytosolic DNA-sensing pathway WP4655,0.04125490153353225,2.9294755877034357,9.339125251523539,"['CYLD', 'RNF125', 'TRADD', 'FADD', 'POLR2K']",0.7153475850275023,0,0,5
14,Serotonin and anxiety-related events WP3944,0.04184043438534081,8.959232613908872,28.43563741126131,"['CRH', 'HTR2C']",0.7153475850275023,0,0,2
15,Arachidonate Epoxygenase / Epoxide Hydrolase WP678,0.04184043438534081,8.959232613908872,28.43563741126131,"['CYP2C8', 'EPHX2']",0.7153475850275023,0,0,2
16,Eicosanoid metabolism via cytochrome P450 monooxygenases (CYP) pathway WP4720,0.04184043438534081,8.959232613908872,28.43563741126131,"['CYP2C8', 'EPHX2']",0.7153475850275023,0,0,2
17,DNA Repair Pathways Full Network WP4946,0.04193416877747427,2.204378478664193,6.9915264816331755,"['RFC1', 'CENPX', 'POLM', 'TDG', 'APEX1', 'BRCA1', 'GTF2H5', 'RAD54B']",0.7153475850275023,0,0,8
18,Cellular Proteostasis WP4918,0.059916287656949244,6.718525179856115,18.91135101179938,"['PFDN4', 'PFDN5']",0.8996504759806049,0,0,2
19,Kennedy pathway from sphingolipids WP3933,0.059916287656949244,6.718525179856115,18.91135101179938,"['CHKA', 'ETNK1']",0.8996504759806049,0,0,2
20,Eukaryotic Transcription Initiation WP405,0.06204486041245551,2.99117529081428,8.315161013720743,"['TAF13', 'POLR1B', 'POLR2I', 'POLR2K']",0.8996504759806049,0,0,4
21,Mitochondrial CII Assembly WP4920,0.06946322762352633,inf,inf,['SDHAF1'],0.9592540957534589,0,0,1
22,Serotonin and anxiety WP3947,0.08010486615408474,5.374100719424461,13.566480221561342,"['CRH', 'HTR2C']",0.9924930832759112,0,0,2
23,Glycosylation and related congenital defects WP4521,0.0949783634297215,3.1027027027027025,7.304091565846497,"['DPM2', 'DPM3', 'MAGT1']",0.9924930832759112,0,0,3
24,mRNA Processing WP411,0.09816233839325751,1.8865698729582576,4.378978941083062,"['LSM7', 'SNRPD1', 'SNRPG', 'SNRPE', 'SNRPB2', 'SRSF9', 'LSM2']",0.9924930832759112,0,0,7
25,Mitochondrial Gene Expression WP391,0.1020265609215999,4.477817745803358,10.220717957422716,"['CAMK4', 'GABPA']",0.9924930832759112,0,0,2
26,CAMKK2  Pathway WP4874,0.10964891968893377,2.880694980694981,6.367694605919741,"['CHRM3', 'FIS1', 'CAMK4']",0.9924930832759112,0,0,3
27,Copper homeostasis WP3286,0.10964891968893377,2.880694980694981,6.367694605919741,"['SCO2', 'COX17', 'ATOX1']",0.9924930832759112,0,0,3
28,Integrated breast cancer pathway WP1984,0.13678792260917919,1.7139085959412639,3.409518754240012,"['TRADD', 'DCAKD', 'BAX', 'FADD', 'BRCA1', 'FAU', 'TGFBR2']",0.9924930832759112,0,0,7
29,Pyrimidine metabolism WP4022,0.1498277139661346,1.7554347826086956,3.33228781301759,"['NT5C', 'POLR1B', 'NME2', 'POLR2I', 'DCTPP1', 'POLR2K']",0.9924930832759112,0,0,6
30,Apoptosis Modulation and Signaling WP1772,0.16402699074000157,1.8176042226675138,3.2857272974996716,"['ENDOG', 'IL1R1', 'TRADD', 'BAX', 'FADD']",0.9924930832759112,0,0,5
31,Myometrial relaxation and contraction pathways WP289,0.16408149914861728,1.5612121212121213,2.821722342780293,"['IGFBP5', 'RGS16', 'MAFF', 'CAMK2A', 'CRH', 'IGFBP6', 'RYR3', 'GABPA']",0.9924930832759112,0,0,8
32,Host-pathogen interaction of human coronaviruses - apoptosis WP4864,0.17500613705916968,2.9840127897681854,5.200938054228572,"['BAX', 'FADD']",0.9924930832759112,0,0,2
33,MECP2 and Associated Rett Syndrome WP3584,0.19339196551835988,1.8538528569650192,3.0459474279255736,"['BCL6', 'SST', 'RPS6', 'CAMK2A']",0.9924930832759112,0,0,4
34,Control of immune tolerance by vasoactive intestinal peptide WP4484,0.1942721306208512,6.708258527827648,10.991450523003023,['VIP'],0.9924930832759112,0,0,1
35,Gastric acid production WP2596,0.1942721306208512,6.708258527827648,10.991450523003023,['VIP'],0.9924930832759112,0,0,1
36,Glucuronidation WP698,0.1942721306208512,6.708258527827648,10.991450523003023,['UGP2'],0.9924930832759112,0,0,1
37,Hijack of ubiquitination by SARS-CoV-2 WP4860,0.1942721306208512,6.708258527827648,10.991450523003023,['ELOB'],0.9924930832759112,0,0,1
38,LDLRAD4 and what we know about it WP4904,0.1942721306208512,6.708258527827648,10.991450523003023,['TGFBR2'],0.9924930832759112,0,0,1
39,Non-homologous end joining WP438,0.1942721306208512,6.708258527827648,10.991450523003023,['POLM'],0.9924930832759112,0,0,1
40,Androgen receptor signaling pathway WP138,0.20016080398619163,1.680605786618445,2.703479971212507,"['SUMO1', 'KAT5', 'BAG1', 'BRCA1', 'PARK7']",0.9924930832759112,0,0,5
41,PPAR-alpha pathway WP2878,0.20085339987563508,2.685251798561151,4.3103124575344065,"['CPT1A', 'PLTP']",0.9924930832759112,0,0,2
42,Novel intracellular components of RIG-I-like receptor (RLR) pathway WP3865,0.20805716323892212,1.7918170878459687,2.8130496439339803,"['CYLD', 'RNF125', 'TRADD', 'FADD']",0.9924930832759112,0,0,4
43,VEGFA-VEGFR2 Signaling Pathway WP3888,0.21897919957365083,1.2510309278350515,1.9000389170549687,"['RAB4A', 'SET', 'RPS6', 'SARS', 'RPL10A', 'RPL7', 'CYP2C8', 'RPL18A', 'TMSB4X', 'MMRN2', 'GRB10', 'RPLP2', 'RPL27', 'RPL26', 'FADD', 'WASF1', 'CCT7', 'CGNL1']",0.9924930832759112,0,0,18
44,TP53 network WP1742,0.22709585414064268,2.4408109875735775,3.6182169233520423,"['SUMO1', 'BAX']",0.9924930832759112,0,0,2
45,DNA IR-double strand breaks and cellular response via ATM WP3959,0.23062356901583203,1.9186615186615186,2.814615950590793,"['KAT5', 'BAX', 'BRCA1']",0.9924930832759112,0,0,3
46,Kit receptor signaling pathway WP304,0.2496245710975965,1.8312039312039312,2.5413396983055376,"['RPS6', 'GRB10', 'CRKL']",0.9924930832759112,0,0,3
47,Serotonin Transporter Activity WP1455,0.25026161450326134,4.471573907839617,6.1942408260683814,['IL1R1'],0.9924930832759112,0,0,1
48,Acetylcholine Synthesis WP528,0.25026161450326134,4.471573907839617,6.1942408260683814,['CHKA'],0.9924930832759112,0,0,1
49,Sulindac Metabolic Pathway WP2542,0.25026161450326134,4.471573907839617,6.1942408260683814,['MSRB3'],0.9924930832759112,0,0,1
50,Codeine and Morphine Metabolism WP1604,0.25026161450326134,4.471573907839617,6.1942408260683814,['CYP2C8'],0.9924930832759112,0,0,1
51,Dual hijack model of Vif in HIV infection WP3300,0.25026161450326134,4.471573907839617,6.1942408260683814,['ELOB'],0.9924930832759112,0,0,1
52,EV release from cardiac cells and their functional effects WP3297,0.25026161450326134,4.471573907839617,6.1942408260683814,['RGS16'],0.9924930832759112,0,0,1
53,Mammary gland development pathway - Involution (Stage 4 of 4) WP2815,0.25026161450326134,4.471573907839617,6.1942408260683814,['BAX'],0.9924930832759112,0,0,1
54,MFAP5-mediated ovarian cancer cell motility and invasiveness WP3301,0.25026161450326134,4.471573907839617,6.1942408260683814,['RYR3'],0.9924930832759112,0,0,1
55,FBXL10 enhancement of MAP/ERK signaling in diffuse large B-cell lymphoma WP4553,0.25355427030945504,2.2371103117505995,3.069712199464093,"['BCL6', 'H2AFZ']",0.9924930832759112,0,0,2
56,22q11.2 copy number variation syndrome WP4657,0.2537407533319877,1.6282682419866534,2.233075762657293,"['RANBP1', 'MRPL40', 'EMC10', 'CRKL']",0.9924930832759112,0,0,4
57,Alzheimer's disease WP2059,0.2537407533319877,1.6282682419866534,2.233075762657293,"['ATP5MD', 'CHPF2', 'FADD', 'RYR3']",0.9924930832759112,0,0,4
58,EGF/EGFR signaling pathway WP437,0.2749636322172733,1.3635813672111312,1.760542315770811,"['NDUFA13', 'ATXN2', 'PXDN', 'CAMK2A', 'GRB10', 'NEDD8', 'CRKL']",0.9924930832759112,0,0,7
59,Histone Modifications WP2369,0.28007233174628215,2.064748201438849,2.627820276927499,"['SETD2', 'SET']",0.9924930832759112,0,0,2
60,Cytosine methylation WP3585,0.3023669126127923,3.3532315978456015,4.010847449305957,['TDG'],0.9924930832759112,0,0,1
61,Ethanol metabolism resulting in production of ROS by CYP2E1 WP4269,0.3023669126127923,3.3532315978456015,4.010847449305957,['MAFF'],0.9924930832759112,0,0,1
62,Leptin and adiponectin WP3934,0.3023669126127923,3.3532315978456015,4.010847449305957,['CPT1A'],0.9924930832759112,0,0,1
63,MicroRNA for Targeting Cancer Growth and Vascularization in Glioblastoma WP3593,0.3023669126127923,3.3532315978456015,4.010847449305957,['VEGFB'],0.9924930832759112,0,0,1
64,miR-509-3p alteration of YAP1/ECM axis WP3967,0.3023669126127923,3.3532315978456015,4.010847449305957,['THBS2'],0.9924930832759112,0,0,1
65,Peroxiredoxin 2 induced ovarian failure WP4873,0.3023669126127923,3.3532315978456015,4.010847449305957,['BAX'],0.9924930832759112,0,0,1
66,IL-2 signaling pathway WP49,0.3065143257243016,1.9170092497430626,2.266845772538264,"['RPS6', 'CRKL']",0.9924930832759112,0,0,2
67,Allograft Rejection WP2328,0.30770652567913703,1.6108108108108108,1.8985157789605651,"['HLA-B', 'HLA-DRA', 'GABPA']",0.9924930832759112,0,0,3
68,Pathways in clear cell renal cell carcinoma WP4018,0.3172815536848005,1.451458678895502,1.6662248034990608,"['SETD2', 'TOX2', 'GRB10', 'PFKM']",0.9924930832759112,0,0,4
69,IL-18 signaling pathway WP4754,0.325285001939141,1.2340247574439611,1.3858758869633452,"['KCNH2', 'CPT1A', 'NACA', 'TMSB4X', 'RGS16', 'COX17', 'BAX', 'NDUFC1', 'FADD']",0.9924930832759112,0,0,9
70,Tamoxifen metabolism WP691,0.350857032492334,2.682226211849192,2.8093005767903967,['CYP2C8'],0.9924930832759112,0,0,1
71,Biomarkers for pyrimidine metabolism disorders WP4584,0.350857032492334,2.682226211849192,2.8093005767903967,['NT5C'],0.9924930832759112,0,0,1
72,Cytokines and Inflammatory Response WP530,0.350857032492334,2.682226211849192,2.8093005767903967,['HLA-DRA'],0.9924930832759112,0,0,1
73,Insulin signaling in adipocytes (diabetic condition) WP3635,0.350857032492334,2.682226211849192,2.8093005767903967,['RPS6'],0.9924930832759112,0,0,1
74,Insulin signaling in adipocytes (normal condition) WP3634,0.350857032492334,2.682226211849192,2.8093005767903967,['RPS6'],0.9924930832759112,0,0,1
75,"Metabolic pathway of LDL, HDL and TG, including diseases WP4522",0.350857032492334,2.682226211849192,2.8093005767903967,['ANXA2'],0.9924930832759112,0,0,1
76,Pathogenesis of SARS-CoV-2 Mediated by nsp9-nsp10 Complex WP4884,0.350857032492334,2.682226211849192,2.8093005767903967,['HLA-DRA'],0.9924930832759112,0,0,1
77,Pyrimidine metabolism and related diseases WP4225,0.350857032492334,2.682226211849192,2.8093005767903967,['NT5C'],0.9924930832759112,0,0,1
78,Nucleotide-binding Oligomerization Domain (NOD) pathway WP1433,0.3587178710309196,1.67693345323741,1.719224162122625,"['NDUFA13', 'COPS6']",0.9924930832759112,0,0,2
79,Parkinson's disease pathway WP2371,0.3587178710309196,1.67693345323741,1.719224162122625,"['ATXN2', 'PARK7']",0.9924930832759112,0,0,2
80,Renin-angiotensin-aldosterone system (RAAS) WP4756,0.3587178710309196,1.67693345323741,1.719224162122625,"['CAMK4', 'CAMK2A']",0.9924930832759112,0,0,2
81,PPAR signaling pathway WP3942,0.366205973605292,1.4376447876447875,1.444199491070253,"['CPT1A', 'FABP6', 'PLTP']",0.9924930832759112,0,0,3
82,16p11.2 proximal deletion syndrome WP4949,0.3819140379836822,1.3091485427489653,1.2601336641141614,"['PPP4R2', 'TMEM219', 'SEZ6L2', 'CCT7']",0.9924930832759112,0,0,4
83,Base Excision Repair WP4752,0.38429305795583313,1.5780787134997885,1.509195334161,"['TDG', 'APEX1']",0.9924930832759112,0,0,2
84,Integrated Cancer Pathway WP1971,0.38429305795583313,1.5780787134997885,1.509195334161,"['BAX', 'BRCA1']",0.9924930832759112,0,0,2
85,Monoamine GPCRs WP58,0.38429305795583313,1.5780787134997885,1.509195334161,"['CHRM3', 'HTR2C']",0.9924930832759112,0,0,2
86,Oxidation by Cytochrome P450 WP43,0.38429305795583313,1.5780787134997885,1.509195334161,"['CYP2C8', 'CYP20A1']",0.9924930832759112,0,0,2
87,Amplification and Expansion of Oncogenic Pathways as Metastatic Traits WP3678,0.39598238313072126,2.234889287851586,2.070369154990401,['EPAS1'],0.9924930832759112,0,0,1
88,Transcriptional cascade regulating adipogenesis WP4211,0.39598238313072126,2.234889287851586,2.070369154990401,['DDIT3'],0.9924930832759112,0,0,1
89,Cell-type Dependent Selectivity of CCK2R Signaling WP3679,0.39598238313072126,2.234889287851586,2.070369154990401,['RYR3'],0.9924930832759112,0,0,1
90,Genes targeted by miRNAs in adipocytes WP1992,0.39598238313072126,2.234889287851586,2.070369154990401,['TMSB4X'],0.9924930832759112,0,0,1
91,Hematopoietic Stem Cell Gene Regulation by GABP alpha/beta Complex WP3657,0.39598238313072126,2.234889287851586,2.070369154990401,['GABPA'],0.9924930832759112,0,0,1
92,Mitochondrial LC-Fatty Acid Beta-Oxidation WP368,0.39598238313072126,2.234889287851586,2.070369154990401,['CPT1A'],0.9924930832759112,0,0,1
93,White fat cell differentiation WP4149,0.4094161419662841,1.4902078337330136,1.3307901358330536,"['DDIT3', 'NR2F2']",0.9924930832759112,0,0,2
94,One-carbon metabolism and related pathways WP3940,0.4094161419662841,1.4902078337330136,1.3307901358330536,"['CHKA', 'ETNK1']",0.9924930832759112,0,0,2
95,SARS-CoV-2 innate immunity evasion and cell-specific immune response WP5039,0.4094161419662841,1.4902078337330136,1.3307901358330536,"['TRADD', 'FADD']",0.9924930832759112,0,0,2
96,Male infertility WP4673,0.41406124401008315,1.2479220888254554,1.1003445493585318,"['RFC1', 'HLA-DRA', 'HORMAD1', 'LRWD1']",0.9924930832759112,0,0,4
97,"GPCRs, Class A Rhodopsin-like WP455",0.4191473112970905,1.1978493929217255,1.0415693876033432,"['CHRM3', 'GPR22', 'NPY1R', 'HTR2C', 'OR6A2']",0.9924930832759112,0,0,5
98,Common Pathways Underlying Drug Addiction WP2636,0.4340265232021364,1.4115865202574782,1.1781801716171956,"['CAMK4', 'CAMK2A']",0.9924930832759112,0,0,2
99,p38 MAPK Signaling Pathway WP400,0.4340265232021364,1.4115865202574782,1.1781801716171956,"['TRADD', 'DDIT3']",0.9924930832759112,0,0,2
100,Canonical and non-canonical TGF-B signaling WP3874,0.43797605785474436,1.9153629135675814,1.5813064454854273,['TGFBR2'],0.9924930832759112,0,0,1
101,Follicle Stimulating Hormone (FSH) signaling pathway WP2035,0.43797605785474436,1.9153629135675814,1.5813064454854273,['RPS6'],0.9924930832759112,0,0,1
102,Glycerolipids and Glycerophospholipids WP4722,0.43797605785474436,1.9153629135675814,1.5813064454854273,['ETNK1'],0.9924930832759112,0,0,1
103,Homologous recombination WP186,0.43797605785474436,1.9153629135675814,1.5813064454854273,['RAD54B'],0.9924930832759112,0,0,1
104,IL1 and megakaryocytes in obesity WP2865,0.43797605785474436,1.9153629135675814,1.5813064454854273,['IL1R1'],0.9924930832759112,0,0,1
105,Interactions between immune cells and microRNAs in tumor microenvironment WP4559,0.43797605785474436,1.9153629135675814,1.5813064454854273,['TGFBR2'],0.9924930832759112,0,0,1
106,MTHFR deficiency WP4288,0.43797605785474436,1.9153629135675814,1.5813064454854273,['CHKA'],0.9924930832759112,0,0,1
107,Overview of nanoparticle effects WP3287,0.43797605785474436,1.9153629135675814,1.5813064454854273,['BAX'],0.9924930832759112,0,0,1
108,PI3K/AKT/mTOR - VitD3 signaling WP4141,0.43797605785474436,1.9153629135675814,1.5813064454854273,['HLA-DRA'],0.9924930832759112,0,0,1
109,DNA damage response WP707,0.44264459569624254,1.2572635135135135,1.0246547995340183,"['RFC1', 'BAX', 'BRCA1']",0.9924930832759112,0,0,3
110,Energy Metabolism WP1541,0.4580741703836664,1.3408273381294964,1.0468163025092734,"['CAMK4', 'GABPA']",0.9924930832759112,0,0,2
111,Interferon type I signaling pathways WP585,0.4580741703836664,1.3408273381294964,1.0468163025092734,"['RPS6', 'CRKL']",0.9924930832759112,0,0,2
112,Head and Neck Squamous Cell Carcinoma WP4674,0.46122434079521163,1.219000819000819,0.9433490352480856,"['RPS6', 'FADD', 'TGFBR2']",0.9924930832759112,0,0,3
113,miRNA regulation of DNA damage response WP1530,0.46122434079521163,1.219000819000819,0.9433490352480856,"['RFC1', 'BAX', 'BRCA1']",0.9924930832759112,0,0,3
114,Serotonin Receptor 2 and ELK-SRF/GATA4 signaling WP732,0.4770550299198666,1.675718132854578,1.2402382489166277,['HTR2C'],0.9924930832759112,0,0,1
115,Apoptosis Modulation by HSP70 WP384,0.4770550299198666,1.675718132854578,1.2402382489166277,['FADD'],0.9924930832759112,0,0,1
116,Computational Model of Aerobic Glycolysis WP4629,0.4770550299198666,1.675718132854578,1.2402382489166277,['PFKM'],0.9924930832759112,0,0,1
117,Deregulation of Rab and Rab Effector Genes in Bladder Cancer WP2291,0.4770550299198666,1.675718132854578,1.2402382489166277,['SYTL3'],0.9924930832759112,0,0,1
118,Fatty acid transporters WP5061,0.4770550299198666,1.675718132854578,1.2402382489166277,['FABP6'],0.9924930832759112,0,0,1
119,Nucleotide metabolism WP404,0.4770550299198666,1.675718132854578,1.2402382489166277,['NME2'],0.9924930832759112,0,0,1
120,Regulation of sister chromatid separation at the metaphase-anaphase transition WP4240,0.4770550299198666,1.675718132854578,1.2402382489166277,['ANAPC11'],0.9924930832759112,0,0,1
121,Selenium Micronutrient Network WP15,0.49754188968771496,1.149034749034749,0.8021130363085937,"['SELENOM', 'SELENOK', 'SELENOH']",0.9924930832759112,0,0,3
122,Apoptosis WP254,0.49754188968771496,1.149034749034749,0.8021130363085937,"['TRADD', 'BAX', 'FADD']",0.9924930832759112,0,0,3
123,TNF-alpha signaling pathway WP231,0.49754188968771496,1.149034749034749,0.8021130363085937,"['TRADD', 'BAX', 'FADD']",0.9924930832759112,0,0,3
124,Parkin-Ubiquitin Proteasomal System pathway WP2359,0.49754188968771496,1.149034749034749,0.8021130363085937,"['PSMC5', 'PSMC4', 'PSMC1']",0.9924930832759112,0,0,3
125,MET in type 1 papillary renal cell carcinoma WP4205,0.504327063735876,1.2186069326357096,0.8341733513811975,"['RPL11', 'CRKL']",0.9924930832759112,0,0,2
126,Modulators of TCR signaling and T cell activation WP5072,0.504327063735876,1.2186069326357096,0.8341733513811975,"['NDUFB10', 'ELOB']",0.9924930832759112,0,0,2
127,Rett syndrome causing genes WP4312,0.504327063735876,1.2186069326357096,0.8341733513811975,"['GPS2', 'TBL1X']",0.9924930832759112,0,0,2
128,BMP2-WNT4-FOXO1 pathway in primary endometrial stromal cell differentiation WP3876,0.5134212649635238,1.4893277478555755,0.9928731387096558,['SST'],0.9924930832759112,0,0,1
129,Hypertrophy Model WP516,0.5134212649635238,1.4893277478555755,0.9928731387096558,['IL1R1'],0.9924930832759112,0,0,1
130,Kallmann's Syndrome WP5074,0.5134212649635238,1.4893277478555755,0.9928731387096558,['CHD7'],0.9924930832759112,0,0,1
131,miRNA targets in ECM and membrane receptors WP2911,0.5134212649635238,1.4893277478555755,0.9928731387096558,['THBS2'],0.9924930832759112,0,0,1
132,NAD Metabolism in Oncogene-Induced Senescence and Mitochondrial Dysfunction-Associated Senescence WP5046,0.5134212649635238,1.4893277478555755,0.9928731387096558,['SCO2'],0.9924930832759112,0,0,1
133,Regulation of apoptosis by parathyroid hormone-related protein WP3872,0.5134212649635238,1.4893277478555755,0.9928731387096558,['BAX'],0.9924930832759112,0,0,1
134,Nucleotide Excision Repair WP4753,0.5264750945680935,1.1654676258992807,0.747707214900617,"['RFC1', 'GTF2H5']",0.9924930832759112,0,0,2
135,Statin inhibition of cholesterol production WP430,0.547262757597514,1.3402154398563735,0.8079170218783811,['PLTP'],0.9924930832759112,0,0,1
136,Striated Muscle Contraction Pathway WP383,0.547262757597514,1.3402154398563735,0.8079170218783811,['TPM2'],0.9924930832759112,0,0,1
137,Ebstein-Barr virus LMP1 signaling WP262,0.547262757597514,1.3402154398563735,0.8079170218783811,['TRADD'],0.9924930832759112,0,0,1
138,Hereditary leiomyomatosis and renal cell carcinoma pathway WP4206,0.547262757597514,1.3402154398563735,0.8079170218783811,['RPS6'],0.9924930832759112,0,0,1
139,Metabolism of Spingolipids in ER and Golgi apparatus WP4142,0.547262757597514,1.3402154398563735,0.8079170218783811,['B3GALT2'],0.9924930832759112,0,0,1
140,PI3K-AKT-mTOR signaling pathway and therapeutic opportunities WP3844,0.547262757597514,1.3402154398563735,0.8079170218783811,['GRB10'],0.9924930832759112,0,0,1
141,Pregnane X receptor pathway WP2876,0.547262757597514,1.3402154398563735,0.8079170218783811,['PSMC5'],0.9924930832759112,0,0,1
142,Regucalcin in proximal tubule epithelial kidney cells WP4838,0.547262757597514,1.3402154398563735,0.8079170218783811,['BAX'],0.9924930832759112,0,0,1
143,NRF2 pathway WP2884,0.5660441121947094,1.011102785913766,0.5754016767575472,"['SLC6A16', 'MAFF', 'FTL', 'TGFBR2']",0.9924930832759112,0,0,4
144,Calcium Regulation in the Cardiac Cell WP536,0.5668555349715634,0.9997031119268036,0.5674822673772965,"['CHRM3', 'RGS16', 'CAMK4', 'CAMK2A', 'RYR3']",0.9924930832759112,0,0,5
145,Synaptic Vesicle Pathway WP2267,0.5687215123160029,1.0719424460431655,0.6049661534737268,"['SLC32A1', 'PARK7']",0.9924930832759112,0,0,2
146,Prader-Willi and Angelman Syndrome WP3998,0.5687215123160029,1.0719424460431655,0.6049661534737268,"['SNURF', 'HTR2C']",0.9924930832759112,0,0,2
147,16p11.2 distal deletion syndrome WP4950,0.5787544961802716,1.218214460584299,0.6662133536281953,['RAB4A'],0.9924930832759112,0,0,1
148,Type II interferon signaling (IFNG) WP619,0.5787544961802716,1.218214460584299,0.6662133536281953,['HLA-B'],0.9924930832759112,0,0,1
149,Neural Crest Cell Migration during Development WP4564,0.5787544961802716,1.218214460584299,0.6662133536281953,['CDH11'],0.9924930832759112,0,0,1
150,"Non-genomic actions of 1,25 dihydroxyvitamin D3 WP4341",0.5887995743584761,1.0305755395683454,0.5458643632159493,"['IFI27L2', 'CAMK2A']",0.9924930832759112,0,0,2
151,Sphingolipid Metabolism (general overview) WP4725,0.6080593608435237,1.1165469778575703,0.5554628820570914,['CERS6'],0.9924930832759112,0,0,1
152,Sphingolipid Metabolism (integrated pathway) WP4726,0.6080593608435237,1.1165469778575703,0.5554628820570914,['CERS6'],0.9924930832759112,0,0,1
153,Cell migration and invasion through p75NTR WP4561,0.6080593608435237,1.1165469778575703,0.5554628820570914,['CDH11'],0.9924930832759112,0,0,1
154,Fluoropyrimidine Activity WP1601,0.6080593608435237,1.1165469778575703,0.5554628820570914,['TDG'],0.9924930832759112,0,0,1
155,Heart Development WP1591,0.6080593608435237,1.1165469778575703,0.5554628820570914,['VEGFB'],0.9924930832759112,0,0,1
156,Hypothesized Pathways in Pathogenesis of Cardiovascular Disease WP3668,0.6080593608435237,1.1165469778575703,0.5554628820570914,['TGFBR2'],0.9924930832759112,0,0,1
157,Methionine De Novo and Salvage Pathway WP3580,0.6080593608435237,1.1165469778575703,0.5554628820570914,['MSRB3'],0.9924930832759112,0,0,1
158,miRNA regulation of p53 pathway in prostate cancer WP3982,0.6080593608435237,1.1165469778575703,0.5554628820570914,['BAX'],0.9924930832759112,0,0,1
159,Neural Crest Cell Migration in Cancer WP4565,0.6080593608435237,1.1165469778575703,0.5554628820570914,['CDH11'],0.9924930832759112,0,0,1
160,Thyroid stimulating hormone (TSH) signaling pathway WP2032,0.6081750634342837,0.9922728483879563,0.4934498505976651,"['APEX1', 'RPS6']",0.9924930832759112,0,0,2
161,B Cell Receptor Signaling Pathway WP23,0.6137723028012042,0.9566280566280566,0.46696006050564776,"['BCL6', 'CAMK2A', 'CRKL']",0.9924930832759112,0,0,3
162,RAC1/PAK1/p38/MMP2 Pathway WP3303,0.6268485411056385,0.9567060637204522,0.4468298815919696,"['GRB14', 'BAX']",0.9924930832759112,0,0,2
163,7-oxo-C and 7beta-HC pathways WP5064,0.6353289603718101,1.030520646319569,0.4674569090013603,['EPHX2'],0.9924930832759112,0,0,1
164,Unfolded protein response WP4925,0.6353289603718101,1.030520646319569,0.4674569090013603,['DDIT3'],0.9924930832759112,0,0,1
165,DNA Mismatch Repair WP531,0.6353289603718101,1.030520646319569,0.4674569090013603,['RFC1'],0.9924930832759112,0,0,1
166,Endothelin Pathways WP2197,0.6353289603718101,1.030520646319569,0.4674569090013603,['NPY1R'],0.9924930832759112,0,0,1
167,Extracellular vesicle-mediated signaling in recipient cells WP2870,0.6353289603718101,1.030520646319569,0.4674569090013603,['TGFBR2'],0.9924930832759112,0,0,1
168,Neurodegeneration with brain iron accumulation (NBIA) subtypes pathway WP4577,0.6353289603718101,1.030520646319569,0.4674569090013603,['FTL'],0.9924930832759112,0,0,1
169,Overview of leukocyte-intrinsic Hippo pathway functions WP4542,0.6353289603718101,1.030520646319569,0.4674569090013603,['FERMT3'],0.9924930832759112,0,0,1
170,Photodynamic therapy-induced unfolded protein response WP3613,0.6353289603718101,1.030520646319569,0.4674569090013603,['DDIT3'],0.9924930832759112,0,0,1
171,PKC-gamma calcium signaling pathway in ataxia WP4760,0.6353289603718101,1.030520646319569,0.4674569090013603,['RYR3'],0.9924930832759112,0,0,1
172,Fas ligand pathway and stress induction of heat shock proteins WP314,0.6607044103900775,0.9567837907155681,0.396537821817587,['FADD'],0.9924930832759112,0,0,1
173,Hematopoietic Stem Cell Differentiation WP2849,0.6607044103900775,0.9567837907155681,0.396537821817587,['KCNH2'],0.9924930832759112,0,0,1
174,Monoamine Transport WP727,0.6607044103900775,0.9567837907155681,0.396537821817587,['IL1R1'],0.9924930832759112,0,0,1
175,Acute viral myocarditis WP4298,0.6621077802225922,0.8926858513189448,0.3680784132198793,"['ENDOG', 'BAX']",0.9924930832759112,0,0,2
176,Exercise-induced Circadian Regulation WP410,0.6621077802225922,0.8926858513189448,0.3680784132198793,"['UGP2', 'SUMO1']",0.9924930832759112,0,0,2
177,Genotoxicity pathway WP4286,0.6621077802225922,0.8926858513189448,0.3680784132198793,"['RPS27', 'TRIAP1']",0.9924930832759112,0,0,2
178,Sleep regulation WP3591,0.6843170588137341,0.8928785158587672,0.3386991186493533,['CRH'],0.9924930832759112,0,0,1
179,IL-5 signaling pathway WP127,0.6843170588137341,0.8928785158587672,0.3386991186493533,['RPS6'],0.9924930832759112,0,0,1
180,Interleukin-11 Signaling Pathway WP2332,0.6843170588137341,0.8928785158587672,0.3386991186493533,['RPS6'],0.9924930832759112,0,0,1
181,Melatonin metabolism and effects WP3298,0.6843170588137341,0.8928785158587672,0.3386991186493533,['CAMK2A'],0.9924930832759112,0,0,1
182,SARS-CoV-2 mitochondrial interactions WP5038,0.6843170588137341,0.8928785158587672,0.3386991186493533,['NDUFB9'],0.9924930832759112,0,0,1
183,Pathways affected in adenoid cystic carcinoma WP3651,0.6946399569666274,0.8366681654676259,0.3048497641397733,"['SETD2', 'BRCA1']",0.9924930832759112,0,0,2
184,Signal transduction through IL1R WP4496,0.7062891604044879,0.8369614003590664,0.29103704782316153,['IL1R1'],0.9924930832759112,0,0,1
185,Signaling of Hepatocyte Growth Factor Receptor WP313,0.7062891604044879,0.8369614003590664,0.29103704782316153,['CRKL'],0.9924930832759112,0,0,1
186,Sphingolipid pathway WP1422,0.7062891604044879,0.8369614003590664,0.29103704782316153,['CERS6'],0.9924930832759112,0,0,1
187,Amyotrophic lateral sclerosis (ALS) WP2447,0.7062891604044879,0.8369614003590664,0.29103704782316153,['BAX'],0.9924930832759112,0,0,1
188,TNF related weak inducer of apoptosis (TWEAK) Signaling Pathway WP2036,0.7062891604044879,0.8369614003590664,0.29103704782316153,['FADD'],0.9924930832759112,0,0,1
189,Disruption of postsynaptic signaling by CNV WP4875,0.7062891604044879,0.8369614003590664,0.29103704782316153,['CAMK2A'],0.9924930832759112,0,0,1
190,Fatty acid beta-oxidation WP143,0.7062891604044879,0.8369614003590664,0.29103704782316153,['CPT1A'],0.9924930832759112,0,0,1
191,Gastric Cancer Network 2 WP2363,0.7062891604044879,0.8369614003590664,0.29103704782316153,['SNURF'],0.9924930832759112,0,0,1
192,IL17 signaling pathway WP2112,0.7062891604044879,0.8369614003590664,0.29103704782316153,['IL17RE'],0.9924930832759112,0,0,1
193,Oxysterols derived from cholesterol WP4545,0.7062891604044879,0.8369614003590664,0.29103704782316153,['EPHX2'],0.9924930832759112,0,0,1
194,DNA IR-damage and cellular response via ATR WP4016,0.709912386462078,0.8112055809897537,0.2779301584700636,"['BCL6', 'BRCA1']",0.9924930832759112,0,0,2
195,Leptin signaling pathway WP2034,0.709912386462078,0.8112055809897537,0.2779301584700636,"['RPS6', 'BAX']",0.9924930832759112,0,0,2
196,Ebola Virus Pathway on Host WP4217,0.7104937006997513,0.8191947049089906,0.2799968159508067,"['RFC1', 'HLA-B', 'HLA-DRA']",0.9924930832759112,0,0,3
197,Nuclear Receptors Meta-Pathway WP2882,0.7143097271581255,0.8552727272727273,0.2877467753730433,"['CPT1A', 'PSMC5', 'SLC6A16', 'MAFF', 'BAX', 'PLTP', 'FTL', 'TGFBR2']",0.9924930832759112,0,0,8
198,Thymic Stromal LymphoPoietin (TSLP) Signaling Pathway WP2203,0.7267345056589509,0.7876227690358011,0.25140450924981256,['RPS6'],0.9924930832759112,0,0,1
199,GABA receptor Signaling WP4159,0.7267345056589509,0.7876227690358011,0.25140450924981256,['SLC32A1'],0.9924930832759112,0,0,1
200,Glycogen Synthesis and Degradation WP500,0.7267345056589509,0.7876227690358011,0.25140450924981256,['UGP2'],0.9924930832759112,0,0,1
201,7q11.23 copy number variation syndrome WP4932,0.7344416898875912,0.786857445680975,0.242859359815274,"['ATP5PO', 'ATP5F1E', 'ATP5MC1']",0.9924930832759112,0,0,3
202,Gastrin signaling pathway WP4659,0.7344416898875912,0.786857445680975,0.242859359815274,"['KAT5', 'ANXA2', 'RPS6']",0.9924930832759112,0,0,3
203,Synaptic signaling pathways associated with autism spectrum disorder WP4539,0.7457590055702809,0.7437662078595652,0.21818588459935861,['CAMK4'],0.9924930832759112,0,0,1
204,ATM Signaling Pathway WP2516,0.7457590055702809,0.7437662078595652,0.21818588459935861,['BRCA1'],0.9924930832759112,0,0,1
205,Host-pathogen interaction of human coronaviruses - MAPK signaling WP4877,0.7457590055702809,0.7437662078595652,0.21818588459935861,['DDIT3'],0.9924930832759112,0,0,1
206,NO/cGMP/PKG mediated Neuroprotection WP4008,0.7457590055702809,0.7437662078595652,0.21818588459935861,['CAMK2A'],0.9924930832759112,0,0,1
207,Nuclear receptors WP170,0.7457590055702809,0.7437662078595652,0.21818588459935861,['NR2F2'],0.9924930832759112,0,0,1
208,Peptide GPCRs WP24,0.7457590055702809,0.7437662078595652,0.21818588459935861,['NPY1R'],0.9924930832759112,0,0,1
209,Prostaglandin Synthesis and Regulation WP98,0.7457590055702809,0.7437662078595652,0.21818588459935861,['ANXA2'],0.9924930832759112,0,0,1
210,Chromosomal and microsatellite instability in colorectal cancer  WP4216,0.7519304515549554,0.7433053557154277,0.21192486325906099,"['BAX', 'TGFBR2']",0.9924930832759112,0,0,2
211,Fragile X Syndrome  WP4549,0.7568000546824165,0.7569607343192248,0.2109317934402343,"['CPT1A', 'CAMK4', 'CAMK2A']",0.9924930832759112,0,0,3
212,Aryl Hydrocarbon Receptor Pathway WP2873,0.7634612362529987,0.7045261268071435,0.1901466183205066,['BAX'],0.9924930832759112,0,0,1
213,Hepatitis C and Hepatocellular Carcinoma WP3646,0.7634612362529987,0.7045261268071435,0.1901466183205066,['BRCA1'],0.9924930832759112,0,0,1
214,IL-6 signaling pathway WP364,0.7634612362529987,0.7045261268071435,0.1901466183205066,['VIP'],0.9924930832759112,0,0,1
215,Photodynamic therapy-induced HIF-1 survival signaling WP3614,0.7634612362529987,0.7045261268071435,0.1901466183205066,['BAX'],0.9924930832759112,0,0,1
216,Pre-implantation embryo WP3527,0.7634612362529987,0.7045261268071435,0.1901466183205066,['DDIT3'],0.9924930832759112,0,0,1
217,Regulation of Microtubule Cytoskeleton WP2038,0.7634612362529987,0.7045261268071435,0.1901466183205066,['CAMK4'],0.9924930832759112,0,0,1
218,Corticotropin-releasing hormone signaling pathway WP2355,0.7769427319174727,0.70399469897766,0.17768026142259272,"['CAMK2A', 'CRH']",0.9924930832759112,0,0,2
219,Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling WP3850,0.7799329464912397,0.6692100538599641,0.16633037144736046,['IGFBP5'],0.9924930832759112,0,0,1
220,Intracellular trafficking proteins involved in CMT neuropathy WP4856,0.7799329464912397,0.6692100538599641,0.16633037144736046,['RAB4A'],0.9924930832759112,0,0,1
221,Insulin Signaling WP481,0.7920902866917275,0.7321101824835567,0.1706401646936954,"['RAB4A', 'GRB14', 'GRB10', 'PFKM']",0.9924930832759112,0,0,4
222,ATM Signaling Network in Development and Disease  WP3878,0.7952595292683325,0.6372574164315636,0.14598724044340905,['KAT5'],0.9924930832759112,0,0,1
223,IL-3 signaling pathway WP286,0.7952595292683325,0.6372574164315636,0.14598724044340905,['CRKL'],0.9924930832759112,0,0,1
224,ErbB signaling pathway WP673,0.7997216743545071,0.6686151079136691,0.1494298060303069,"['CAMK2A', 'CRKL']",0.9924930832759112,0,0,2
225,Endoplasmic reticulum stress response in coronavirus infection WP4861,0.809520461676935,0.6082095642239269,0.12852272707768958,['DDIT3'],0.9924930832759112,0,0,1
226,Glycolysis and Gluconeogenesis WP534,0.809520461676935,0.6082095642239269,0.12852272707768958,['PFKM'],0.9924930832759112,0,0,1
227,Thermogenesis WP4321,0.8103198376785635,0.6522196876645026,0.13717891972688528,"['CPT1A', 'RPS6']",0.9924930832759112,0,0,2
228,EGFR Tyrosine Kinase Inhibitor Resistance WP4806,0.8103198376785635,0.6522196876645026,0.13717891972688528,"['RPS6', 'BAX']",0.9924930832759112,0,0,2
229,TGF-beta Receptor Signaling WP560,0.8227897139250835,0.5816876122082585,0.11346085766333266,['TGFBR2'],0.9924930832759112,0,0,1
230,DNA Replication WP466,0.8227897139250835,0.5816876122082585,0.11346085766333266,['RFC1'],0.9924930832759112,0,0,1
231,p53 transcriptional gene network WP4963,0.8227897139250835,0.5816876122082585,0.11346085766333266,['BAX'],0.9924930832759112,0,0,1
232,Pancreatic adenocarcinoma pathway WP4263,0.8300265663643588,0.6217165802241927,0.1158242887684672,"['BAX', 'TGFBR2']",0.9924930832759112,0,0,2
233,Ferroptosis WP4313,0.8351361304656845,0.5573758228605625,0.1004171275136125,['FTL'],0.9924930832759112,0,0,1
234,"GPCRs, Other WP117",0.8351361304656845,0.5573758228605625,0.1004171275136125,['CHRM3'],0.9924930832759112,0,0,1
235,IL-1 signaling pathway WP195,0.8351361304656845,0.5573758228605625,0.1004171275136125,['IL1R1'],0.9924930832759112,0,0,1
236,Photodynamic therapy-induced AP-1 survival signaling. WP3611,0.8351361304656845,0.5573758228605625,0.1004171275136125,['BAX'],0.9924930832759112,0,0,1
237,Vitamin D Receptor Pathway WP2877,0.8391935673660931,0.6462946817785528,0.1133044328921857,"['IGFBP5', 'BCL6', 'ZNF257']",0.9924930832759112,0,0,3
238,Hepatitis B infection WP4666,0.8391935673660931,0.6462946817785528,0.1133044328921857,"['BAX', 'FADD', 'TGFBR2']",0.9924930832759112,0,0,3
239,Regulation of Actin Cytoskeleton WP51,0.8391935673660931,0.6462946817785528,0.1133044328921857,"['CHRM3', 'TMSB4X', 'WASF1']",0.9924930832759112,0,0,3
240,Association Between Physico-Chemical Features and Toxicity Associated Pathways WP3680,0.8466237842759364,0.5350089766606823,0.08907838331987916,['TMSB4X'],0.9924930832759112,0,0,1
241,TGF-beta receptor signaling in skeletal dysplasias WP4816,0.8466237842759364,0.5350089766606823,0.08907838331987916,['TGFBR2'],0.9924930832759112,0,0,1
242,Translation inhibitors in chronically activated PDGFRA cells WP4566,0.8466237842759364,0.5350089766606823,0.08907838331987916,['RPS6'],0.9924930832759112,0,0,1
243,Sudden Infant Death Syndrome (SIDS) Susceptibility Pathways WP706,0.8466700282058525,0.6359502359502359,0.10585025199854703,"['KCNH2', 'CPT1A', 'SST']",0.9924930832759112,0,0,3
244,Metapathway biotransformation Phase I and II WP702,0.8466700282058525,0.6359502359502359,0.10585025199854703,"['CYP2C8', 'EPHX2', 'CYP20A1']",0.9924930832759112,0,0,3
245,Wnt signaling WP428,0.8478700586406094,0.5939248601119105,0.09801416509700854,"['CAMK2A', 'NKD1']",0.9924930832759112,0,0,2
246,Brain-derived neurotrophic factor (BDNF) signaling pathway WP2380,0.8538430237017599,0.6259290540540541,0.09890174482210948,"['CAMK4', 'RPS6', 'CAMK2A']",0.9924930832759112,0,0,3
247,Proximal tubule transport WP4917,0.857312307197547,0.5143626570915619,0.07918767807449026,['SLC7A9'],0.9924930832759112,0,0,1
248,Complement system WP2806,0.8765101046478948,0.4774942292895614,0.06293710397900312,['RPS19'],0.9924930832759112,0,0,1
249,DNA damage response (only ATM dependent) WP710,0.8785394845092372,0.5451475554250477,0.07059357031644042,"['BCL6', 'BAX']",0.9924930832759112,0,0,2
250,Regulation of toll-like receptor signaling pathway WP1449,0.8785394845092372,0.5451475554250477,0.07059357031644042,"['CYLD', 'FADD']",0.9924930832759112,0,0,2
251,Structural Pathway of Interleukin 1 (IL-1) WP2637,0.8851190982199554,0.46096700303349225,0.056253217981275874,['IL1R1'],0.9924930832759112,0,0,1
252,AMP-activated protein kinase (AMPK) signaling WP1403,0.9005811820591455,0.4311113685063995,0.04514381239288277,['CPT1A'],0.9924930832759112,0,0,1
253,Endometrial cancer WP4155,0.9005811820591455,0.4311113685063995,0.04514381239288277,['BAX'],0.9924930832759112,0,0,1
254,Oncostatin M Signaling Pathway WP2374,0.9005811820591455,0.4311113685063995,0.04514381239288277,['RPS6'],0.9924930832759112,0,0,1
255,Translation Factors WP107,0.9075146495881925,0.4175830341113106,0.04052458364137267,['EEF1B2'],0.9924930832759112,0,0,1
256,Joubert Syndrome WP4656,0.9075146495881925,0.4175830341113106,0.04052458364137267,['KAT5'],0.9924930832759112,0,0,1
257,ncRNAs involved in Wnt signaling in hepatocellular carcinoma WP4336,0.9075146495881925,0.4175830341113106,0.04052458364137267,['NKD1'],0.9924930832759112,0,0,1
258,Spinal Cord Injury WP2431,0.908844352940644,0.494337863042899,0.04724951903919247,"['IL1R1', 'APEX1']",0.9924930832759112,0,0,2
259,TGF-beta Signaling Pathway WP366,0.908844352940644,0.494337863042899,0.04724951903919247,"['SUMO1', 'TGFBR2']",0.9924930832759112,0,0,2
260,Melanoma WP4685,0.9139653723687473,0.4048745987704695,0.036423569173045324,['BAX'],0.9924930832759112,0,0,1
261,Prolactin Signaling Pathway WP2037,0.9139653723687473,0.4048745987704695,0.036423569173045324,['RPS6'],0.9924930832759112,0,0,1
262,Mesodermal commitment pathway WP2857,0.9188582488293767,0.47655447070914697,0.040327666049363886,"['SETD2', 'RPL38']",0.9924930832759112,0,0,2
263,Wnt signaling pathway and pluripotency WP399,0.919966905526006,0.3929137184496779,0.03277591226499558,['NKD1'],0.9924930832759112,0,0,1
264,Endochondral Ossification with Skeletal Dysplasias WP4808,0.919966905526006,0.3929137184496779,0.03277591226499558,['SLC38A2'],0.9924930832759112,0,0,1
265,Endochondral Ossification WP474,0.919966905526006,0.3929137184496779,0.03277591226499558,['SLC38A2'],0.9924930832759112,0,0,1
266,MAPK Signaling Pathway WP382,0.9236177061310602,0.5838171377811617,0.04638837636072168,"['DUSP4', 'IL1R1', 'DDIT3', 'CRKL', 'TGFBR2']",0.9924930832759112,0,0,5
267,Toll-like Receptor Signaling Pathway WP75,0.9255504754971444,0.38163631700436007,0.029525908035046018,['FADD'],0.9924930832759112,0,0,1
268,Non-small cell lung cancer WP4255,0.9255504754971444,0.38163631700436007,0.029525908035046018,['BAX'],0.9924930832759112,0,0,1
269,LncRNA involvement in canonical Wnt signaling and colorectal cancer WP4258,0.9307451416632784,0.37098543786155996,0.026625545503505883,['NKD1'],0.9924930832759112,0,0,1
270,Circadian rhythm related genes WP3594,0.9310196841568336,0.5060554225111187,0.036170239921070456,"['CPT1A', 'CRH', 'RPS27A']",0.9924930832759112,0,0,3
271,Ectoderm Differentiation WP2858,0.9319587469980726,0.4521399829289111,0.03186082526450652,"['NR2F2', 'TBL1X']",0.9924930832759112,0,0,2
272,T-cell receptor (TCR) signaling pathway WP69,0.9355779464043746,0.36091028191566793,0.024033310232236035,['CRKL'],0.9924930832759112,0,0,1
273,Retinoblastoma gene in cancer WP2446,0.9355779464043746,0.36091028191566793,0.024033310232236035,['H2AFZ'],0.9924930832759112,0,0,1
274,Adipogenesis WP236,0.9430416112662166,0.4300881875145045,0.02522246620957173,"['EPAS1', 'DDIT3']",0.9924930832759112,0,0,2
275,Glioblastoma signaling pathways WP2261,0.9442568850454811,0.34230999401555956,0.01963388318121331,['BRCA1'],0.9924930832759112,0,0,1
276,Thyroid hormones production and their peripheral downstream signaling effects WP4746,0.9481482288657098,0.33370736086175945,0.017768058011330277,['RPS6'],0.9924930832759112,0,0,1
277,Pathways Regulating Hippo Signaling WP4540,0.9551361634130809,0.3177310421475592,0.014584289863896071,['CDH11'],0.9924930832759112,0,0,1
278,Breast cancer pathway WP4262,0.9577953701107497,0.3977236121550521,0.017150289580972082,"['BAX', 'BRCA1']",0.9924930832759112,0,0,2
279,Senescence and Autophagy in Cancer WP615,0.9582691838526038,0.3103001962339777,0.013227028458192716,['IGFBP5'],0.9924930832759112,0,0,1
280,Genes related to primary cilium development (based on CRISPR) WP4536,0.9582691838526038,0.3103001962339777,0.013227028458192716,['TTC30B'],0.9924930832759112,0,0,1
281,Hippo-Merlin Signaling Dysregulation WP4541,0.9664173747446262,0.28994614003590663,0.009904407379638365,['CDH11'],0.9925962937711281,0,0,1
282,Focal Adhesion WP306,0.9672741951407792,0.4290613193839,0.014276273707049656,"['VEGFB', 'THBS2', 'CRKL']",0.9925962937711281,0,0,3
283,Focal Adhesion-PI3K-Akt-mTOR-signaling pathway WP3932,0.9690667359204154,0.49533076030336565,0.015564183362880065,"['PIK3IP1', 'EPAS1', 'RPS6', 'VEGFB', 'THBS2']",0.9925962937711281,0,0,5
284,Small cell lung cancer WP4658,0.9797769586797862,0.2514142474848413,0.005136475138899817,['BAX'],0.9925962937711281,0,0,1
285,Cell cycle WP179,0.9825064378830894,0.2422066264077036,0.004274555237117666,['ANAPC11'],0.9925962937711281,0,0,1
286,Chemokine signaling pathway WP3929,0.983729964245677,0.2378494485765581,0.0039016457663889384,['CRKL'],0.9925962937711281,0,0,1
287,Endoderm differentiation WP2853,0.9848680449804051,0.23364515417808435,0.0035625304862579215,['DUSP4'],0.9925962937711281,0,0,1
288,Epithelial to mesenchymal transition in colorectal cancer WP4239,0.9859266371740624,0.22958583544852348,0.0032539961848395684,['TGFBR2'],0.9925962937711281,0,0,1
289,Ciliopathies WP4803,0.989173547930538,0.29852073397461804,0.0032495428415017257,"['XPNPEP3', 'AK7']",0.9925962937711281,0,0,2
290,PI3K-Akt signaling pathway WP4172,0.9937974250150851,0.3649943981078053,0.0022709553119817857,"['RPS6', 'VEGFB', 'BRCA1', 'THBS2']",0.9937974250150851,0,0,4
